Clinical Trial Update: Safety and Pharmacokinetics of Rezafungin [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics update for rezafungin; the trial was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Fungal Infection | Phase 1 | Status: TERMINATED | Results posted: 2021-07-16